SARS-CoV-2, HIV and Hepatitis C – what do these viruses have in common? They can be targeted with antiviral medications, which have changed the way we’re able to manage these diseases, as well as prevent and control their spread. As we face the possibility of emerging and re-emerging infectious diseases, as well as the increase in antimicrobial-resistant strains, major questions arise when it comes to the viability of developing new antiviral agents. We explore whether cannabis compounds may offer promise, with food scientist Associate Professor Choo Wee Sim and molecular virologist Associate Professor Sharifah Syed Hassan.

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek

Leave a Reply

Your email address will not be published.